胺碘酮治疗急诊快速心律失常的效果及安全性分析

Amiodarone treatment,efficacy,and safety analysis of emergency rapid arrhythmia

目的分析胺碘酮治疗急诊快速心律失常的效果及安全性。方法选取98例快速心律失常患者临床资料给予分析,按照不同的医治药物,可分研究组(49例)和对照组(49例),研究组行胺碘酮医治,而对照组行普罗帕酮医治,比对两组医治前后血压与心率水平、BNP与心电图情况以及不良反应情况。结果医治前两组血压与心率水平、BNP与心电图情况对比差异无统计学意义,医治后研究组血压与心率水平、BNP与心电图情况优于对照组(P<0.05);而不良反应总发生率对比差异无统计学意义。结论给予快速心律失常患者胺碘酮药物医治可降低血压、BNP以及心率水平,缩小P-R间期,而且药物不良反应轻微,值得推广。

Objective To analyze amiodarone treatment,efficacy,and safety of emergency rapid arrhythmia.Methods To select98cases of rapidarrhythmia patients clinical data was analyzed,according to the different treatment drugs,can be divided into research group(49cases)and controlgroup(49cases),the team line amiodarone treatment,while control group line propafenone treatment,compared two groups of treatment before andafter the blood pressure and heart rate,the BNP and electrocardiogram(ecg)and adverse reactions.Results To heal the former two groups of bloodpressure and heart rate,the BNP and electrocardiogram(ecg),there was no statistically significant difference compared with heal team after the bloodpressure and heart rate,the BNP and electrocardiogram(ecg)is superior to the control group(P<0.05);But always there was no statistically significantdifference compared with the incidence of adverse reactions.Conclusion Rapid arrhythmia in patients with amiodarone drug treatment can reduceblood pressure,the BNP and heart rate,reduce P-R interphase,and minor adverse drug reactions,is worth promoting.